Group 1 - A-shares indices collectively strengthened on May 29, with the Hong Kong Stock Connect medical theme index leading the gains [1] - The Hong Kong medical ETF (159366) rose by 2.9%, with notable increases in constituent stocks such as WuXi AppTec up over 10%, MicroPort Medical up over 9%, and WuXi Biologics up over 8% [1] - The U.S. International Trade Court halted Trump's tariff policy, leading to significant gains in U.S. stock index futures, with the Dow Jones futures up nearly 500 points (1.1% increase) [1] Group 2 - At the 2025 ASCO annual meeting, Chinese pharmaceutical companies showcased strong performance in innovative drug fields, particularly in PD-1 bispecific antibodies, CAR-T, and ADC technologies [2] - Key focus areas include the technological accumulation and market expansion capabilities of leading innovative drug and medical device companies, especially those with core technologies and overseas licensing [2]
港股医疗ETF（159366）盘中涨近3%，药明合联涨超10%，机构：创新管线进入密集收获期